Edition:
United States

Immune Pharmaceuticals Inc (IMNP.OQ)

IMNP.OQ on NASDAQ Stock Exchange Capital Market

0.25USD
18 May 2018
Change (% chg)

$0.00 (+0.60%)
Prev Close
$0.25
Open
$0.25
Day's High
$0.26
Day's Low
$0.24
Volume
196,718
Avg. Vol
214,415
52-wk High
$3.43
52-wk Low
$0.24

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.146
FY 2017 Dec '17 0.00 -0.695
Sep '17 0.00 -0.534
Jun '17 0.00 -0.500
Mar '17 0.00 -0.427
FY 2016 Dec '16 0.00 -1.538
Sep '16 0.00 -3.139
Jun '16 0.00 -2.659
Mar '16 0.00 -3.486
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Jun-18 1 -0.21 -0.21 -0.21 --
Quarter Ending Sep-18 1 -0.09 -0.09 -0.09 --
Year Ending Dec-18 1 -0.51 -0.51 -0.51 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.57 32.53
P/E High - Last 5 Yrs. -- 41.44 47.11
P/E Low - Last 5 Yrs. -- 23.40 24.61
Beta 1.60 0.80 0.79
Price to Sales (TTM) -- 4.06 8.85
Price to Book (MRQ) 0.86 3.49 4.22
Price to Tangible Book (MRQ) -- 4.40 5.79
Price to Cash Flow (TTM) -- 19.79 21.98
% Owned Institutions 1.75 1.27 2.39

Dividends

  Company industry sector
Dividend Yield -- 1.80 1.67
Dividend Yield - 5 Year Avg -- 0.79 0.80
Dividend 5 Year Growth Rate -- 2.73 4.12
Payout Ratio(TTM) -- 16.85 17.66

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.97 5.06
Sales (TTM) vs TTM 1 Yr. Ago -- 10.12 12.43
Sales - 5 Yr. Growth Rate -- 7.45 8.11
EPS (MRQ) vs Qtr. 1 Yr. Ago 65.74 37.00 32.52
EPS (TTM) vs TTM 1 Yr. Ago 75.84 -- --
EPS - 5 Yr. Growth Rate -- 7.09 8.54
Capital Spending - 5 Yr. Growth Rate 1.49 8.30 8.79

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.52 2.50
Current Ratio (MRQ) 0.31 3.58 3.56
LT Debt to Equity (MRQ) 15.33 10.34 12.76
Total Debt to Equity (MRQ) 49.24 12.69 15.69
Interest Coverage (TTM) -1.23 40.07 34.90

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.56 54.71
Gross Margin - 5 Yr. Avg. -- 52.71 52.74
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -314,023.81 18.51 15.91
Operating Margin (TTM) -- 13.07 -1.83
Operating Margin - 5 Yr. Avg. -373,319.09 14.25 11.18
Pre-Tax Margin (TTM) -- 13.35 0.25
Pre-Tax Margin - 5 Yr. Avg. -494,452.41 14.52 11.38
Net Profit Margin (TTM) -- 9.76 -3.16
Net Profit Margin - 5 Yr. Avg. -470,557.19 10.80 7.67
Effective Tax Rate (TTM) -- 22.46 31.64
Effective Tax Rate - 5 Yr. Avg. -- 23.90 24.59

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 836,134,495 726,901,196
Net Income/Employee (TTM) -2,902,857 97,299,163 84,519,443
Receivable Turnover (TTM) -- 5.53 5.67
Inventory Turnover (TTM) -- 2.49 3.53
Asset Turnover (TTM) 0.00 0.87 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -94.05 10.46 9.99
Return on Assets - 5 Yr. Avg. -70.07 11.69 11.11
Return on Investment (TTM) -158.24 13.08 12.63
Return on Investment - 5 Yr. Avg. -98.22 15.12 14.39
Return on Equity (TTM) -414.55 14.80 14.50
Return on Equity - 5 Yr. Avg. -310.45 16.36 15.75
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 76.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Immune Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 1.75%
# of Holders: 18
Total Shares Held: 561,311
3 Mo. Net Change: -127,017
# New Positions: 4
# Closed Positions: 2
# Increased Positions: 8
# Reduced Positions: 4
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.